| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 433.77 mm | 433.77 mm | 433.77 mm | 433.77 mm | 433.77 mm | 433.77 mm |
| Cash burn (monthly) | 65.49 mm | (no burn) | 32.31 mm | 22.27 mm | 26.81 mm | 12.96 mm |
| Cash used (since last report) | 294.45 mm | n/a | 145.28 mm | 100.13 mm | 120.54 mm | 58.28 mm |
| Cash remaining | 139.32 mm | n/a | 288.49 mm | 333.64 mm | 313.23 mm | 375.50 mm |
| Runway (months of cash) | 2.1 | n/a | 8.9 | 15.0 | 11.7 | 29.0 |
| 13F holders | Current |
|---|---|
| Total holders | 192 |
| Opened positions | 31 |
| Closed positions | 23 |
| Increased positions | 77 |
| Reduced positions | 49 |
| 13F shares | Current |
|---|---|
| Total value | 3.28 tn |
| Total shares | 79.89 mm |
| Total puts | 299.50 k |
| Total calls | 242.90 k |
| Total put/call ratio | 1.2 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 6.87 mm | $343.42 bn |
| RTW Investments | 4.17 mm | $208.30 bn |
| Deerfield Management | 3.41 mm | $170.29 bn |
| Flynn James E | 3.41 mm | $174.79 mm |
| Commodore Capital | 3.35 mm | $167.37 bn |
| Wellington Management | 2.89 mm | $144.26 bn |
| Biotechnology Value Fund L P | 2.75 mm | $0.00 |
| Samlyn Capital | 2.61 mm | $130.42 bn |
| Paradigm Biocapital Advisors | 2.45 mm | $122.65 bn |
| BEN Franklin Resources | 2.26 mm | $117.72 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 29 Jan 25 | Sven Ante Lundberg | Share Option Common Shares | Grant | Acquire A | No | No | 41.65 | 300,000 | 12.50 mm | 300,000 |
| 29 Jan 25 | Perry Gregory D | Share Option Common Shares | Grant | Acquire A | No | No | 41.65 | 100,000 | 4.17 mm | 100,000 |
| 29 Jan 25 | Fabian Zohren | Share Option Common Shares | Grant | Acquire A | No | No | 41.65 | 50,000 | 2.08 mm | 50,000 |
| 29 Jan 25 | Silverman Peter B. | Share Option Common Shares | Grant | Acquire A | No | No | 41.65 | 125,000 | 5.21 mm | 125,000 |
| 29 Jan 25 | Harry Shuman | Share Option Common Shares | Grant | Acquire A | No | No | 41.65 | 23,420 | 975.44 k | 23,420 |
